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 Lymphomas  
Classification of lymphomas 
Lymphomas are malignancies of the lymphoid cells 
Lymphomas  
Hodgkin’s 
lymphomas 
Non 
hodgkin’s  
lymphoma 
WHO classification of tumors of hematopoietic 
and lymphoid tissues 2008 
• B-cell lymphoma 
• account for about 85% of the diagnosed 
cases, and within Africa,  Burkitt lymphoma 
is the most common B-cell tumour 
• T-cell lymphoma 
• NK-cell 
lymphomas 
1. Non-Hodgkin's 
  lymphomas 
2. Hodgkin's 
  lymphoma 
Hodgkin lymphoma 
 British physician, considered 
one of the most prominent 
pathologists of his time and a 
pioneer in preventive medicine. 
 In 1832, Dr. Thomas Hodgkin, 
working at Guy’s 
Hospital in London, reported a 
series of seven cases 
of enlargement of the lymph 
nodes and spleen, 
which he speculated might 
represent a primary disorder of 
those tissues rather than 
reactive enlargement Dr. Thomas Hodgkin 
(1798-1866) 
Dr. Dorothy Reed Mendenhall  
• The first descriptions of the 
microscopic appearance of the 
affected tissues appeared in 
the late 1800s. However, it was 
not until the seminal 
observations by Sternberg in 
1898 and Reed in 19025 that 
widespread attention was 
drawn to the curious giant cell 
present in many such cases, 
which would later come to bear 
their names and which would 
soon become regarded as a 
morphologic hallmark of 
Hodgkin’s disease. Interestingly, 
neither Sternberg nor Reed felt 
that this disorder represented a 
neoplasm. Sternberg believed 
that it was a variant of 
tuberculosis, whereas Reed felt 
it to be an independent entity 
of inflammatory origin. 
Definition  
Hodgkin lymphoma (formerly, Hodgkin 
disease) is a potentially curable lymphoma 
with distinct histology, biologic behavior, 
and clinical characteristics.  
Classification WHO (2000)  
• Hodgkin lymphoma can be divided into two 
main types:  
 
Classical Hodgkin 
lymphomas 
Nodular 
lymphocyte-
predominant 
Hodgkin lymphoma 
1. Nodular  sclerosis 
2. Mixed  cellularity 
3. lymphocyte-
depleted 
4. Lymphocyte-rich 
PATHOGENESIS 
• In classic HD has been proven to be a malignant tumor of B-cell Origin 
• PCR studies have provided evidence to suggest that the RS cells of classic HD are 
derived from germinal center B cells that have undergone unusual “crippling” 
mutations of their immunoglobulin genes, rendering them nonfunctional—providing 
a fascinating clue as to why this B-cell neoplasm appears so different from all others. 
•  During normal B-cell development, naïve B lymphocytes (which have few or no 
mutations in their immunoglobulin genes) enter germinal centers where, upon 
exposure to antigen, they undergo high rates of mutation of their immunoglobulin 
gene variable regions. This process, termed somatic hypermutation, is a key process 
in generating a diverse antibody repertoire and serves to increase the likelihood that 
high-affinity antibody is produced against a foreign antigen. Only B cells that are 
successful in creating immunoglobulin with high affinity for the antigen presented 
are permitted to leave the germinal center to become either plasma cells or 
memory B cells.  
• B cells that cannot make antibody undergo apoptosis and die.  
• Cells  are “rescued” from apoptosis only if they produce high-affinity antibody; 
this rescue appears to involve activation of the bcl-2 anti-apoptosis gene.  
• Epstein-Barr virus subsequently has been found to latently infect the RS cells in 
the majority of cases of classic HD. Infection  by EBV can cause up-regulation of the 
bcl-2 gene, thereby allowing the cell to avoid apoptosis 
 
PATHOGENESIS 
 
PATHOGENESIS 
germinal 
centre 
B cell 
transforming 
event(s) 
loss of apoptosis 
RS cell 
inflammatory 
response 
EBV? 
cytokines 
Clinical Presentation 
• Nontender lymph nodes enlargement ( localised ) 
– neck and supraclavicular area   60-80% 
– mediastinal adenopathy   50% 
– other ( abdominal, extranodal disease ) 
• systemic symptoms (B symptoms)  30% 
– fever  
– night sweats 
– unexplained weight loss  (10% per 6 months) 
• other symptoms  
– fatigue, weakness, pruritus 
– cough , chest pain, shortness of breath, vena cava syndrome 
– abdominal pain, bowel disturbances, ascites 
– bone pain 
– cachexia, anemia, splenomegaly, hepatomegaly, jundice Rarely 
– Pel-Ebstein fever is a rarely seen condition noted in patients with Hodgkin's lymphoma in which the 
patient experiences fevers which cyclicly increase then decrease over an average period of one or 
two weeks. A cyclic fever may also be associated with other conditions, but it is not called "Pel-
Ebstein fever" unless the fever is associated with Hodgkin's. 
 
Symptoms related lymph nodes 
enlargement  
I. Enlarged, painless, non-tender, superficial 
lymph nodes 
II.Alcohol-induced pain Rarely, patients with 
Hodgkin’s lymphoma complain of severe pain 
following alcohol ingestion. The pain typically 
occurs within a few minutes after the 
ingestion of even a small amount of alcohol. 
The mechanism is unknown. 
 
Symptoms related to mass 
 
1. Mediastinal mass: 
    retrosternal chest pain, cough, or shortness of 
breath.  
2.  Retroperitoneal lymphadenopathy 
     discomfort and pain in the paravertebral or 
loin regions, particularly in the supine 
position.   
Cotswolds staging classification 
Ann Arbor classification (1971г) 
Stage I Stage II Stage III Stage IV 
Classical Hodgkin Lymphoma 
                         
                                    
                  
Hodgkin lymphoma generally involves contiguous nodes. 
Non-Hodgkin lymphoma is noncontiguous. 
Enlarged lymph nodes in the supraclavicular region in HL 
patients. 
Cervical lymphadenopathy in HL 
 pruritus in HL 
Here is a 5 cm lymph node (obviously from a patient with lymphadenopathy). The node 
should normally be soft and pink and less than 1 cm in size. This lymph node is 
involved with Hodgkin's disease. This gross appearance could pass for a non-Hodgkin's 
lymphoma as well. 
Group of mediastinal lymph nodes. Note the anthracotic pigment in some 
lymph nodes. The specimen measured 12 cm. in greatest dimension.  
This is a liver that is involved with Hodgkin's disease. 
Staging evaluation for Hodgkin’s Disease (1) 
• Essential 
– pathologic documentation by hemopathologist 
– physical examination 
– documentation of B symptoms 
– laboratory evaluation 
• complete blood count, ESR 
• liver function tests 
• renal function tests 
• lactate dehydrogenase 
– chest radiograph 
– ultrasonography 
– CT scan of chest, abdomen and pelvis 
– bone marrow aspiration / biopsy (bilateral) 
Staging evaluation for Hodgkin’s Disease (2) 
• Essential under certain circumstances 
– liver biopsy 
– gallium scan 
– technetium bone scan 
– bone radiographs 
– MRI  
– bipedal lymphangiogram 
– staging laparotomy 
• Useful but not essential tests 
– cell-surface marker phenotypic analysis 
– gene rearrangement analysis 
Hodgkin's disease. This contrast-enhanced computed tomographic scan of the patient in 
Figure 2 better delineates the extensive anterior mediastinal adenopathy (large arrows) 
from the thymus (arrowhead) and aorta (A). 
>10 cm 
Bulky disease 
This 23 y/o female with left inguinal adenopathy was referred for gallium scan. 
Abdominal and pelvic CT scans were subsequently performed. Selected images 
from the gallium scan demonstrate abnormal uptake in the left inguinal region and 
the left side of the pelvis. The CT scan demonstrates heterogenous masses in these 
regions consistent with lymphadenopathy. In addition, there are multiple low 
attenuation lesions in the spleen.  
Lymphangiography 
 
Abdominal lymphangiogram X-ray of a patient with Hodgkin's 
disease, showing the organization of lymph nodes in the pelvis and 
the back of the abdomen. A lymphangiogram is conducted by 
injecting a radio-opaque liquid dye into the lymph system through the 
feet. The fluid travels through the lymph system and remains visible 
by X-ray 
Diagnosis  
To diagnose Hodgkin lymphoma a histologic evaluation is always 
required, and an excisional lymph node biopsy is recommended for 
this purpose. 
Comparison between two types  
Classical Hodgkin lymphomas 
Nodular lymphocyte-predominant 
Hodgkin lymphoma 
•Only 1 in 20 people with Hodgkin 
lymphoma. Typically affects people aged 30–
50 and  it is more common in men.  
•So  called a ‘popcorn cell’  is unique to this 
kind of Hodgkin lymphoma.  
•It has a very good prognosis and over 90% of 
people go into remission  after an excision 
biopsy and  radiotherapy.  
•NLPHL can relapse later on and require 
another course of treatment and this  can 
occur after as long as 10 years after 
treatment has finished. In some cases, the 
relapse takes the form of a non-Hodgkin 
lymphoma (this process of a lymphoma 
coming back in a  different form is known as 
‘transformation’). 
About 19 out of 20 people with 
Hodgkin lymphoma. 
Reed–Sternberg cell unique to this kind 
of Hodgkin lymphoma.  
Characteristic CHL NLPHL 
Pattern Diffuse, Interfollicular, Nodular Nodular, at least in part 
Tumour Cells R-S Mononuclear or Lacunar 
Lymphomcytic/Histiocytic or 
Popcorn 
Background 
Lymphocytes ,histiocytes, eosinophils, 
plasma. 
Lymphocytic, Histiocytic. 
Fibrosis Common Rare 
CD15 + ( 85% ) (-) 
CD30 + ( > 95% ) (-) 
CD20 (- / +) (+) 
CD45 (-) (+) 
Epithelial Membrane Antigen (-) (+) 
Nuclear BCL 6 ( PTN in R-S cells ) (-) (+) 
EBV ( in R-S ) cells + ( 50% ) (-) 
Background Lymphocytes T -cells > B-cells B-cells > T-cells 
CD57 T-cells (-) (+) 
Ig genes 
Rearranged, Clonal, Mutated, 
“Crippled” 
Rearranged, Clonal, Mutated, 
Ongoing 
Nodular LPHL and Classical HL Morphologic and 
Immunophenotypic Features. 
Types of cells in HL 
popcorn cell lacunar cell classic RS cell 
(mixed cellularity) (nodular sclerosis) (lymphocyte 
predominance) 
Nodular lymphocyte-
predominant Hodgkin 
lymphoma 
Nodular lymphocyte-predominant 
Hodgkin lymphoma 
• These cells have also been referred to as “popcorn” cells, but the WHO 
classification of 2008 recommended the use of the term “LP cell.” 
•  In comparison with classical HRS cells, the nucleoli of the LP cells are smaller, 
multiple, and basophilic. 
A close-up of L&H cell (popcorn cell) in a case of Nodular 
Lymphocyte-predominant Hodgkin Lymphoma. It has a 
large, multilobed, folded nucleus and is surrounded by 
small lymphocytes. L&H cells are of B-cell lineage and 
express pan-B-cell markers.  
http://www.webpathology.
com/image.asp?case=38
8&n=16 
Classical Hodgkin lymphomas 
Reed-Sternberg cell 
• Diagnostic RS-cells are large cells (20-50 Mm) in diameter or 
more with abundant weakly acidophilic or amphophilic 
cytoplasm, which may appear homogenous or granular and 
lacks a pale zone in the Golgi area , The nucleus is bilobed or 
polylobed . 
• The nuclear membrane is thick and sharply defined. The 
nuclear pattern is usually vesicular  but with some coarse 
chromatin clumps scattered throughout .There is very large 
,variously shaped, but usually rounded, highly acidophilic 
central inclusion like nucleolus surrounded by a clear halo. 
When the two lobes face each other (mirror image) owl eye 
appearance results. 
• Cells with this set of features but lacking nuclear lobation are 
referred to as mononuclear variant of RS cells or  H-cells 
(Hodgkin's cells).   
 
Reed-Sternberg cell 
Malignant REED-STERNBERG ( RS) Cell: Bi-nucleate cell with a 
prominent nucleolus. Derived from B cell, at an early stage of 
differentiation. 
Classical RS cells 


Nodular sclerosis 
• 70% of all CHL - is the most 
frequent subtype  
• In most cases, NSHL has at least a 
partially nodular pattern, with 
fibrosious bands separating the 
nodules.  
• The disease affects primarily young 
adults and is less often observed in 
the elderly. 
• Female  predominance. 
• In 80% of patients with NSCHL the 
mediastinum is involved and 50% 
of patients with NSCHL present 
with bulky disease.  
 

Mixed cellularity Hodgkin’s disease 
• The appearance is usually 
diffuse or vaguely nodular, 
without bands forming 
sclerosis.  
• The overall prognosis is also 
worse than in LP or NS HD 
but varies with stage, and the 
disease can be cured in many 
patients.  
• At low power, the involved 
tissue appears diffusely 
effaced by a mixed cellular 
infiltrate consisting of 
scattered diagnostic RS cells 
and  varying proportions of 
mature small lymphocytes, 
large lymphocytes, 
histiocytes, eosinophils, and 
plasma cells  

Lymphocyte Rich 
• Some cases of the CHL with RS-
cells of the classical type or 
lacunar type may have a 
background infiltrate that consist 
predominantly of lymphocytes, 
with rare or no eosinophils, the 
term lymphocyte rich CHL was 
proposed. 
•The frequency of <10% 
•It is more common in young men 
•Usually found in stage I and 
progresses slowly 
•The prognosis is very good 
 
Lymphocyte depleted  
 
 
• Is the least common 
subtype of CHL   
•The pattern in LDHL is 
diffuse and often appears 
hypocellular ,due to the 
presence of fibrosis , 
necrosis, and a paucity of 
inflammatory cells.  
•Large number of classical 
RS-cells are present with a 
bizarre pleomorphic 
sarcomatous variants.  
•Approximately 70% of 
patients present at an 
advanced stage and most 
(80%) have B symptoms.  
IMMUNOHISTOCHEMISTRY OF HODGKIN’S 
LYMPHOMA 
 • The diagnosis of Hodgkin’s lymphoma is primarily based on the recognition 
of the typical tumor cells, either HRS 
cells or LP cells, in the appropriate 
environment.  
• In addition immunophenotypic and 
molecular markers help to classify the 
disease into the various tumor 
subtypes. 
• In nearly all cases of CHL, HRS cells are 
positive for CD30. In addition, the 
majority of HRS cells (85%) also 
express CD15 
• LP cells are usually negative for both 
CD15 and CD30. The B-cell markers 
CD20 and CD79a are positive in nearly 
all cases of NLPHL.  
Reed-Sternberg cells and most 
Hodgkin variants express the 
monoclonal antigens 
Treatment of Hodgkin Disesae 
With appropriate treatment about 85% of patients 
with Hodgkin disease are curable 
 
• I A,B:  radiation therapy 
• II A  : combination chemotherapy ( ABVD
 
 
Adriamycin, Bleomycin, Vinblastine and 
Dacarbazine) +  radiotherapy 
• IIB  IIIA,B   IVA,B :     
  combination chemotherapy (+/- 
radiotherapy)  
Irradiation fields used in Hodgkin’s Lymphoma 
Outcomes of HL 
In assessing the long-term 20-year results of 
treatment it has been established: 
1.During the first 5-8 years after the end of 
treatment, the patients mostly die from Hodgkin's 
disease progression. 
2.After 15-20 years of follow-leading cause of death 
of patients are late complications of treatment: 
• secondary tumors and leukemias (10-30%) 
• myocardial infarction (7-16%) 
• infection (4-10%) 
• serious damage to the lung tissue after 
mediastinal irradiation, particularly when combined 
with bleomycin (6-7%) 
   
Causes of Death among 2733 Patients 
with Hodgkin’s Disease/Lymphoma 
Hodgkin lymphoma 383 41.2% 
Secondary cancers 200 21.5% 
Cardiovascular  148 15.9% 
Pulmonary  41 4.4% 
Infection  35 3.8% 
Trauma/Suicide 16 1.7% 
MDS 11 1.2% 
Other/Unknown 96 10.3% 
Total 930         100.0%
  
Stanford, Hoppe et al 
Prognosis 
• Hodgkin� ' s disease is considered one of the most curable 
forms of cancer, especially if it is diagnosed and treated early.  
• Unlike other cancers, Hodgkin's disease is even potentially 
curable in late stages  
• Five-year survival rates for patients diagnosed with stage I or 
stage II Hodgkin� ' s disease are 90 - 95%.  
• With advances in treatment, recent studies have indicated that 
even patients with advanced Hodgkin� ' s disease have 5-year 
survival rates of 90%, although it is not yet certain if their 
cancer will return. Patients who survive 15 years after 
treatment are more likely to later die from other causes than 
Hodgkin� ' s disease. 
 
Non-Hodgkin lymphomas 
Definition 
• Non-Hodgkin’s lymphoma (NHL) is a heterogeneous group of 
lymphoproliferative malignancies. More than 30 different 
subtypes of NHL have been identified and categorized 
according to several prognostic factors, including size, 
growth rate, and anatomic site. 
Epidemiology: 
 - annual incidence: 5-10 new cases per 100 000 persons, 
 - age distribution: middle-age patients and the elderly, 
 - males are affected more often than females (1.5:1.0). 
 
Risk Factors 
• Most cases of NHL occur in patients who are 
60 years of age or older. 
• NHL occurs more frequently in men than in 
women. 
• Exposure to chemicals such as benzene and 
herbicides has been linked to an increased risk 
of NHL.  
• People with a weakened immune system and 
certain infections, such as HIV, are also at an 
increased risk for NHL. 
Non-Hodgkin’s Lymphoma 
Rappaport Classification 
Nodular (follicular) Diffuse 
Small cell Large cell 
Indolent Aggressive 
The two most often encountered patterns of growth are 1) follicular (sometimes referred to 
as nodular) in which the lymphoma mimics follicular center structures and 2) diffuse in 
which the lymphoid cells proliferate in an apparently unorganized fashion. Occasionally 
lymphoma will be distributed within lymph node sinuses. 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
                                                                       
  
                                                             
  
                                                               
 
Histological comparison of normal lymph 
node and the  lymph node affected by 
lymphoma 
Normal  lymph node Follicular  lymphoma 

WHO Classification: 
B-Cell Malignancies 
Harris NL et al. J Clin Oncol. 1999;17:3835-3849. 
Precursor B-cell neoplasm 
• Precursor B-lymphoblastic leukemia/lymphoma 
Mature (peripheral) B-cell neoplasms 
• B-cell chronic lymphocytic leukemia/ 
small lymphocytic lymphoma  
• B-cell prolymphocytic leukemia  
• Lymphoplasmacytic lymphoma  
• Splenic marginal-zone B-cell lymphoma  
• Nodal marginal-zone lymphoma  
• Extranodal marginal-zone B-cell 
lymphoma, mucosa-associated 
lymphoid tissue (MALT) type  
• Hairy cell leukemia  
• Plasma-cell myeloma/ 
plasmacytoma  
• Follicular lymphoma  
• Mantle-cell lymphoma  
• Diffuse large B-cell lymphoma 
(DLBCL)  
• Burkitt's lymphoma/Burkitt's cell 
leukemia 
• Blastic NK-cell leukemia  
Antigen Expression in B-Cell 
Lineage  
Pre-B Early B Mature B Plasmacytoid B 
Type of B cell lymphoma is a function of: 
1) Where the cell was in development/maturation when it went “bad”  
2) What molecular derangement occurred 
Plasma Activated B Stem cell 
Burkitts, FL, DLBCL WM MM MCL, CLL ALL 
Germinal center 
Jaffe. In: Non-Hodgkin’s Lymphoma. 1997:84. 
WHO Classification: 
T-Cell Malignancies 
Precursor T-cell neoplasm 
• Precursor T-lymphoblastic leukemia/lymphoma 
Mature (peripheral) T-cell neoplasms 
• T-cell prolymphocytic leukemia  
• T-cell granular lymphocytic leukemia  
• Aggressive NK-cell leukemia  
• Adult T-cell lymphoma/leukemia (HTLV1+)  
• Extranodal NK/T-cell lymphoma, nasal type 
• Enteropathy-type T-cell lymphoma  
• Hepatosplenic gamma-delta T-cell 
lymphoma  
• Subcutaneous panniculitis-like T-cell 
lymphoma  
• Mycosis fungoides/Sézary syndrome  
• Primary cutaneous anaplastic large cell 
lymphoma, T/null cell  
• Peripheral T-cell lymphoma, unspecified  
• Angioimmunoblastic T-cell lymphoma  
• Primary systemic anaplastic large cell 
lymphoma, T/null cell 
• Blastic NK lymphoma  
 
Harris NL et al. J Clin Oncol. 1999;17:3835-3849. 

Non-Hodgkin’s Lymphoma 
Working Classification 
• Low Grade 
– Small Lymphocytic 
– Follicular small-cleaved cell 
– Follicular mixed small-cleaved and large cell 
• Intermediate Grade 
– Follicular large cell 
– Diffuse small cleaved cell 
– Diffuse mixed small and large cell 
– Diffuse large cell 
• High Grade 
– Large cell immunoblastic 
– Lymphoblastic 
– Small non-cleaved cell (Burkitt's and non-Burkitt's type) 
Lymphoma Biology 
• Aggressive NHL 
– short natural history (patients die within months if 
untreated) 
– disease of rapid cellular proliferation 
– Potentially curable with chemotherapy 
• Indolent NHL 
– long natural history (patients can live for many 
years untreated) 
– disease of slow cellular accumulation 
– Generally incurable with chemotherapy 
 
Non Hodgkin 
Lymphoma 
Highly 
Aggressive 
Aggressive Indolent 
B cell 
Follicular 
SLL/CLL 
Marginal zone 
LP (WM) 
 
T/NK cell 
Mycosis fungoides 
Sezary syndrome 
Primary cut ALCL 
B cell 
Pre-B 
lymphoblastic 
Burkitt 
 
 
T/NK cell 
Pre-T 
lymphoblastic 
B cell 
DLBCL 
FLg3 and tFL 
Mantle cell 
Primary effusion 
 
T/NK cell 
ALCL 
Angioimmunoblastic 
Subq panniculitis-like 
Blastic NK 
Extnanodal NK/T 
nasal 
Enteropathy-type 
Hepatosplenic 
PTCL nos 
Follicular Lymphoma 
Diffuse Large B Cell Lymphoma 
Non-Hodgkin’s Lymphoma 
Splenic Lymphoma 
Burkitt’s Lymhoma 
Starry, Starry Night 
Clinical Presentation 
• Patients with lymphoma may present with the 
following symptoms: 
•Lympadenopathy similar to tuberculosis 
•Mediastinal mass  
•Pleural effusion 
•Splenomegaly 
•Maxillary mass (Burkitt lymphoma) 
•Right iliac fossa mass 
•Intussusception 
•Bowel obstruction 
•Bowel perforation 
•Fever, weight loss, night sweats 
• Aggressive NHL 
– Patients likely to 
present with 
symptoms 
• Indolent NHL 
– Patients likely to 
present with 
painless 
adenopathy 
 
Denis Parsons Burkitt (28 
February 1911 – 23 March 
1993) 

                     
                            
         
  
Nodular 
non-
Hodgkin's 
lymphoma  
in a 
patient 
with AIDS 
В-клеточная неходжкинская лимфома с поражением илеоцекального угла. 
Non-Hodgkin Lymphoma Diagnosis 
Lymph node biopsy 
• Biopsy of lymph node is the main method 
of diagnosis of lymphoma. 
• Material for morphological study lymph 
node can be obtained by using: 
• aspiration biopsy (suspension cells) 
• needle biopsy (tissue column) 
• open incisional biopsy (a fragment of the 
lymph nodes) 
• open excisional biopsy (the entire lymph 
node or conglomerate lymph nodes). 
Non-Hodgkin’s Lymphoma 
Immunophenotyping 
• Immunohistochemistry 
• Immunofluorescence 
• Flow cytometry 
 
• Identification of CD’s (cluster determinants) 
– CD5 = T cell type 
– CD20 = B cell type 
Immunohistochemistry 
Extranodal NK / T-cell lymphoma, nasal type 
stain on CD3 
Treatment approach 
• Approach dictated mainly by histology 
– reliable hematopathology crucial 
• Aggressive NHL 
– Cure is often the goal 
• Indolent NHL 
– Cure is rarely the goal 
– Control is the goal 
 
 
